Saturn V Capital Management LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Saturn V Capital Management LP disclosed 25 US equity positions worth $279.8m in its Q3 2024 13F filing. The largest position was ASND at 10.7% of the reported book, followed by IRON and PCVX.
What did Saturn V Capital Management LP own in Q3 2024? Top 25 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ASND ASCENDIS PHARMA A/S | Healthcare | 10.7% | $29.9m | 200,285 | – | |
| 2 | IRON DISC MEDICINE INC | Healthcare | 9.0% | $25.1m | 511,041 | – | |
| 3 | PCVX VAXCYTE INC | Healthcare | 8.4% | $23.4m | 204,987 | – | |
| 4 | CGON CG ONCOLOGY INC | Healthcare | 7.0% | $19.6m | 520,119 | – | |
| 5 | COGT COGENT BIOSCIENCES INC | Healthcare | 6.6% | $18.5m | 1,712,899 | – | |
| 6 | CRGX CARGO THERAPEUTICS INC | 6.6% | $18.5m | 1,002,461 | – | ||
| 7 | CYTK CYTOKINETICS INC | Healthcare | 6.3% | $17.5m | 331,283 | – | |
| 8 | PHAT PHATHOM PHARMACEUTICALS INC | 5.7% | $15.8m | 874,590 | – | ||
| 9 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 5.4% | $15.1m | 298,974 | – | |
| 10 | CELC CELCUITY INC | Healthcare | 5.0% | $14.1m | 946,335 | – | |
| 11 | ARGX ARGENX SE | Healthcare | 4.3% | $12.0m | 22,111 | – | |
| 12 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.5% | $9.7m | 501,978 | – | |
| 13 | SLN SILENCE THERAPEUTICS PLC | 3.1% | $8.7m | 481,127 | – | ||
| 14 | ABVX ABIVAX SA | 2.7% | $7.5m | 648,019 | – | ||
| 15 | INOZYME PHARMA INC | 2.6% | $7.2m | 1,368,810 | – | ||
| 16 | MERUS N V | 2.3% | $6.6m | 131,240 | – | ||
| 17 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.3% | $6.4m | 556,489 | – | ||
| 18 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 2.0% | $5.7m | 432,996 | – | |
| 19 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 2.0% | $5.6m | 109,567 | – | ||
| 20 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.6% | $4.6m | 1,120,409 | – | |
| 21 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.9% | $2.6m | 37,432 | – | |
| 22 | 2662247D ITEOS THERAPEUTICS INC | 0.7% | $2.0m | 195,704 | – | ||
| 23 | CTNM CONTINEUM THERAPEUTICS INC | 0.5% | $1.5m | 77,297 | – | ||
| 24 | AVBP ARRIVENT BIOPHARMA INC | 0.4% | $1.1m | 47,266 | – | ||
| 25 | LONGBOARD PHARMACEUTICALS IN | 0.4% | $1.1m | 31,529 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.